Detection of mutant p53 in hepatocellular cancer from turkey and its correlation with clinicopathologic parameters

Digestive Diseases and Sciences

Volumn 48, Issue 5, 2003, Pages 865-869

  Cengiz, Cem ^a   Akarca, Ulus S ^b   Goker, Erdem ^b   Yuce, Gul ^b  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Enzyme linked immunosorbent assay; Hepatocellular carcinoma; Mutation; P53 protein

Indexed keywords

AFLATOXIN B1; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CARCINOGENESIS; CELL DIFFERENTIATION; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE MUTATION; GENE THERAPY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCREENING TEST; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; AGED; BIOPSY, NEEDLE; CARCINOMA, HEPATOCELLULAR; CULTURE TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B; HEPATITIS C, CHRONIC; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; TUMOR SUPPRESSOR PROTEIN P53; TURKEY;

EID: 0037405634     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023031008757     Document Type: Article

References (30)

1. Bosch FX, Ribes J, Borras J: Epidemiology of primary liver cancer. Semin Liver Dis 19:271-285, 1999
2. Simonetti RG, Camma C, Fiorello F, Politi F, D'amico G, Pagliaro L: Hepatocellular carcinoma: a worldwide problem and the major risk factors. Dig Dis Sci 36:962-972, 1991
3. Beasley RP: Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61:1942-1956, 1988
4. Okuda K: Hepatocellular carcinoma: recent progress. Hepatology 15(5):948-63, 1992
5. Caselmann WH, Alt M: Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma. J Hepatol 24(2 suppl):61-66, 1996
6. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y: Hepatitis C virus infection is associated with the development of hepatocellular cancer. Proc Natl Acad Sci USA 87(17):6547-6549, 1990
7. Ozturk M, Bressac B, Puisieux A: p53 mutation in hepatocellular cancer after aflatoxin exposure. Lancet 338:1356-1359, 1991
8. Chen CJ, Wang LY, Lu SN, Wu MH, You SL, Zhang YJ, Wang LW, Santella RM: Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma. Hepatology 24(1):38-42, 1996
9. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH: Mutations in the p53 gene occur in diverse tumor types. Nature 342:705-708, 1989
10. Unsal H, Yakicier C, Marcais C, Kew M, Volkmann M, Zentgraf H, Isselbacher KJ, Ozturk M: Genetic heterogeneity of hepatocellular carcinoma. Proc Natl Acad Sci USA 19:822-826, 1994
11. Bressac B, Kew M, Wands J, Ozturk M: Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350:429-431, 1991
12. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC: Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350:427-428, 1991
13. Kuru U, Senli S, Turel L, Kuru N, Baskent A, Ulucakli O: Age-specific seroprevalence of hepatitis B virus infection. Turk J Pediatr 37(4):331-338, 1995
14. Thomas DL, Mahley RW, Badur S, Palaoglu E, Quinn TC: The epidemiology of hepatitis C in Turkey. Infection 22(6):411-414, 1994
15. Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, Hasnian SS, Leung N, Lesmana L, Phiet PH, Sjalfoellah Noer HM, Sollano J, Sun HS, Xu DZ: Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 15(12): 1356-1361, 2000
16. Kiire CF: Hepatitis B infection in sub-Saharan Africa. The African Regional Study Group. Vaccine 8(suppl): 107-112, 1990
17. Yano M, Yatsuhashi H, Inoue O, Inokuchi K, Koga M: Epidemiology and long term prognosis of hepatitis C virus infection in Japan. Gut 34(2 suppl): S13-S16, 1993
18. Lee SD, Chan CY, Wang YJ, Wu JC, Lai KH, Tsai YT, Lo KJ: Seroepidemiology of hepatitis C virus infection in Taiwan. Hepatology 13(5):830-833, 1991
19. Madhava V, Burgess C, Drucker E: Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis 2(5):293-302, 2002
20. Bourdon J-C, D'Errico A, Paterlini P, Grigioni W, May E, Debuire B: p53 Protein accumulation in European hepatocellular carcinoma is not always dependent on p53 gene mutation. Gastroenterology 108:1176-1182, 1995
21. Hayashi H, Sugio K, Matsumata T, Adachi E, Takenaka K, Sugimachi K: The clinical significance of p53 gene mutation in hepatocellular carcinomas from Japan. Hepatology 22:1702-1707. 1995
22. Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S: p53 Gene mutation spectrum in hepatocellular carcinoma. Cancer Res 52:6358-6364, 1992
23. Ng IO, Lai EC, Chan AS, So MK: Overexpression of p53 in hepatocellular carcinomas: a clinicopathological and prognostic correlation. J Gastroenterol Hepatol 10(3):250-255, 1995
24. Thung SN, Hytiroglou P, Fiel I, Theise N: Preneoplastic lesions in chronic hepatitis C. Princess Takamatsu Symp 25:171-178, 1995
25. Ward J, Robinson PJ: How to detect hepatocellular carcinoma in cirrhosis. Eur Radiol 12(9):2258-2272, 2002
26. Hussain SM, Zondervan PE, IJzermans JN, Schalm SW, de Man RA, Krestin GP: Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. Radiographics 22(5): 1023-1036, 2002
27. Fracanzani AL, Burdick L, Borzio M, Roncalli M, Bonelli N, Borzio F, Maraschi A, Fiorelli G, Fargion S: Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis. Hepatology 34(6): 1109-1112, 2001
28. Okuda T, Hirohashi K, Kinoshita H, Wakasa K, Sakurai M: Characteristic histologic features of human hepatocellular carcinoma with mutant p53 protein. World J Surg 20:215-220, 1996
29. Mise K, Tashiro S, Yogita S, Wada D, Harada M, Fukuda Y, Miyake H, Isikawa M, Izumi K, Sano N: Assesment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis. Clin Cancer Res 4(6):1475-1482, 1998
30. Tanaka S, Toh Y, Adachi E, Matsumata T, Mori R, Sugimachi K: Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation. Cancer Res 53:2884-2887, 1993